179 filings
8-K
TVTX
Travere Therapeutics Inc
24 Apr 24
Other Events
4:05pm
8-K
TVTX
Travere Therapeutics Inc
23 Feb 24
Other Events
4:05pm
8-K
TVTX
Travere Therapeutics Inc
15 Feb 24
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
TVTX
Travere Therapeutics Inc
8 Jan 24
Travere Therapeutics Provides Corporate Update and 2024 Outlook
7:07am
8-K
TVTX
Travere Therapeutics Inc
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
8-K
8rzfe7b7i8 c609
7 Nov 23
Travere Therapeutics Reports Third Quarter 2023 Financial Results
4:04pm
8-K
eo2z4 w9e2i
21 Sep 23
Other Events
7:35am
8-K
n63d8 cn914j467v5
5 Sep 23
Completion of Acquisition or Disposition of Assets
8:35am
8-K
tcoejktergu1kw
3 Aug 23
Travere Therapeutics Reports Second Quarter 2023 Financial Results
4:06pm
8-K
trmgsx 3ri
17 Jul 23
Entry into a Material Definitive Agreement
8:07am
8-K
393y52iyi jwo
31 May 23
Other Events
4:57pm
8-K
51g1gmgbk0 d5o
22 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
0f1r oorg4i49
4 May 23
Travere Therapeutics Reports First Quarter 2023 Financial Results
4:05pm
8-K
xo8wgno269v1ah
1 May 23
Other Events
4:07pm
8-K
kod8fpu 6cssfiz6dniu
12 Apr 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
1rdpy0jp
1 Mar 23
Travere Therapeutics Announces Proposed Public Offering of Common Stock
5:17pm
8-K
7hno6z1m4ef
23 Feb 23
Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
wohiw6z
17 Feb 23
Other Events
4:06pm
8-K
0kd514k8hltubkt ui
9 Jan 23
Travere Therapeutics Provides Corporate Update and 2023 Outlook
7:05am
8-K
3ayhwz4vii2w0kfa19e
27 Oct 22
Travere Therapeutics Reports Third Quarter 2022 Financial Results
4:17pm